Barco, S., Jalaie, H., Sebastian, T., Wolf, S., Fumagalli, R. M., Lichtenberg, M., . . . Kucher, N. (2025). Aspirin plus Rivaroxaban versus Rivaroxaban alone for the prevention of venous stent thrombosis among patients with post-thrombotic syndrome: The multicenter, multinational, randomized, open-label ARIVA trial. Circulation, 151(12), . https://doi.org/10.1161/CIRCULATIONAHA.124.073050
Chicago-Zitierstil (17. Ausg.)Barco, Stefano, et al. "Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients with Post-thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-label ARIVA Trial." Circulation 151, no. 12 (2025). https://doi.org/10.1161/CIRCULATIONAHA.124.073050.
MLA-Zitierstil (9. Ausg.)Barco, Stefano, et al. "Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients with Post-thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-label ARIVA Trial." Circulation, vol. 151, no. 12, 2025, https://doi.org/10.1161/CIRCULATIONAHA.124.073050.